Restrictions on the use of valproate in female patients of reproductive age: the updated recommendations based on recent clinical data
For more than half a century, valproic acid (VA) has been a first-line drug to control seizures in various forms of epilepsy and status epilepticus; VA is also used in bipolar disorders. However, the accumulated clinical evidence indicates negative outcomes of pregnancies in women receiving valproat...
Main Authors: | G. N. Avakyan, D. V. Blinov, G. G. Avakyan, E. S. Akarachkova, S. G. Burd, P. N. Vlasov, K. V. Voronkova, V. I. Guzeva, I. A. Zhidkova, E. A. Katunina, D. I. Korabelnikov, A. V. Lebedeva, L. V. Lipatova, E. A. Morozova, O. M. Oleinikova, I. G. Rudakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2019-07-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/472 |
Similar Items
-
Regulatory restrictions on the use of valproate in girls and women of childbearing potential: status update
by: D. V. Blinov, et al.
Published: (2021-10-01) -
Use of valproates in women of childbearing age and pregnant women with epilepsy
by: P. N. Vlasov
Published: (2015-03-01) -
Valproate in pregnancy: comment from the SAPP
by: Irene Hösli, et al.
Published: (2021-02-01) -
Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data
by: Julia Spoendlin, et al.
Published: (2021-01-01) -
PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY
by: P. A. Balunov
Published: (2017-05-01)